TINKs in CRC patients are polarized towards the CD56brightCD16-CD9+CD49a+ subset (Figure 3B) and can induce in vitro HUVEC proliferation, migration, and vessel formation [22]. The gene discussed is CD9; the disease is colorectal carcinoma.